Article Details

Mirati Therapeutics Receives Approval from the MHRA for KRAZATI (adagrasib) as ... - PR Newswire

Retrieved on: 2023-11-04 15:17:54

Tags for this article:

Click the tags to see associated articles and topics

Mirati Therapeutics Receives Approval from the MHRA for KRAZATI (adagrasib) as ... - PR Newswire. View article details on hiswai:

Excerpt

Mirati Contacts. Investor Relations: ir@mirati.com. Media Relations: media@mirati.com. References. 1 ... Products. For Marketers · For Public Relations ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up